Sector Update: Healthcare Shares Mixed; Johnson & Johnson up 1% on Q3 Results

By Staff,

Shutterstock photo

Healthcare stocks:

JNJ: +1.34%

PFE: -0.24%

ABT: flat

MRK: -0.11%

AMGN: flat

Healthcare shares are mixed in pre-market trade. Johnson & Johnson ( JNJ ) is up 1.3% as it reports Q3 adjusted EPS of $1.36, ahead of the analyst consensus of $1.32 per share on Capital IQ. Sales were $17.6 billion, vs. expectations of $17.4 billion.

The company increased its earnings guidance for full-year 2013 to $5.44 - $5.49 per share. The Street is at $5.46 per share.

And, Omeros ( OMER ) said that the U.S. Food and Drug Administration has approved its study plan for the use of its OMS302 drug in pediatric patients undergoing primary cataract extraction. A successful completion of the plan would make the drug eligible for additional six months of marketing exclusivity in the U.S.

The drug is designed to maintain interoperative pupil dilation, prevent surgically induced pupil constriction and reduce postoperative pain resulting from cataract and other lens replacement surgery.

OMER closed down 2.12% on Monday. The stock is trading at the top end of the 52-week range between $3.65 and $13.76.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: JNJ , OMER

More from MT Newswires


MT Newswires

MT Newswires

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by